FDA Orders New Label For Biogen Idec's MS Drug
November 25, 2014 at 14:05 PM EST
Biogen Idec Inc (NASDAQ: BIIB) was little changed Tuesday when regulators ordered new labeling information for its blockbuster ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.